11. 5-year follow-up of the safety, tolerability and efficacy of subcutaneous trastuzumab for the adjuvant treatment of HER2-positive early breast cancer. Results from the SafeHER Phase III trial. (April 2021) Authors: Gligorov, J.; Pivot, X.; Ataseven, B.; De Laurentiis, M.; Llombart, A.; Jung, K.H.; Manikhas, A.; Azim, H.A.; Alexandrou, A.; Gupta, K.; Herraez-Baranda, L.; Tosti, N.; Restuccia, E. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results. (April 2018) Authors: Pivot, X.; Bondarenko, I.; Nowecki, Z.; Dvorkin, M.; Trishkina, E.; Ahn, J.-H.; Im, S.-A.; Sarosiek, T.; Chatterjee, S.; Wojtukiewicz, M.Z.; Shparyk, Y.; Moiseyenko, V.; Bello, M.; Semiglazov, V.; Lee, Y.; Lim, J. Journal: European journal of cancer Issue: Volume 93(2018) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study. (November 2017) Authors: Pivot, X.; Verma, S.; Fallowfield, L.; Müller, V.; Lichinitser, M.; Jenkins, V.; Sánchez Muñoz, A.; Machackova, Z.; Osborne, S.; Gligorov, J. Journal: European journal of cancer Issue: Volume 86(2017) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial. (4th May 2018) Authors: Adotevi, O.; Godet, Y.; Galaine, J.; Lakkis, Z.; Idirene, I.; Certoux, J. M.; Jary, M.; Loyon, R.; Laheurte, C.; Kim, S.; Dormoy, A.; Pouthier, F.; Barisien, C.; Fein, F.; Tiberghien, P.; Pivot, X.; Valmary-Degano, S.; Ferrand, C.; Morel, P.; Delabrousse, E. Journal: Oncoimmunology Issue: Volume 7:Number 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Melanoma risk‐takers: fathers and sons. (February 2015) Authors: Eisinger, F.; Morère, J.‐F.; Pivot, X.; Grange, F.; Lhomel, C.; Mortier, L.; Robert, C.; Saiag, P.; Sassolas, B.; Viguier, J. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29(2015)Supplement 2 Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. P103 Subcutaneous trastuzumab plus chemotherapy for early breast cancer: interim safety from SafeHer. (March 2015) Authors: Gligorov, J.; De Laurentiis, M.; Verrill, M.; Jung, K.H.; Azim, H.A.; Ataseven, B.; Al-Sakaff, N.; Heinzmann, D.; Shing, M.; Pivot, X. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. P201 Subcutaneous versus intravenous trastuzumab in early breast cancer: 2-year follow-up of HannaH. (March 2015) Authors: Jackisch, C.; Hegg, R.; Stroyakovskiy, D.; Ahn, J.; Melichar, B.; Chen, S.C.; Crepelle-Flechais, A.; Heinzmann, D.; Shing, M.; Pivot, X. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study. (September 2017) Authors: Pivot, X.; Spano, J.P.; Espie, M.; Cottu, P.; Jouannaud, C.; Pottier, V.; Moreau, L.; Extra, J.M.; Lortholary, A.; Rivera, P.; Spaeth, D.; Attar-Rabia, H.; Benkanoun, C.; Dima-Martinez, L.; Esposito, N.; Gligorov, J. Journal: European journal of cancer Issue: Volume 82(2017) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. PONDx, Prospective Multicenter Study of the Oncotype DX Breast Cancer assay: real-life utilization in French clinical practice. (March 2017) Authors: Curtit, E.; Vannetzel, J.-M.; Catala, S.; Darmon, J.-C.; Spaeth, D.; Mansi, L.; Varette, C.; Furtos-Fanget, C.; Mouysset, J.-L.; Pivot, X. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX® Breast Recurrence Score Assay. Issue 5 (May 2017) Authors: Curtit, E.; Mansi, L.; Maisonnette-Escot, Y.; Sautière, J.-L.; Pivot, X. Journal: European journal of surgical oncology Issue: Volume 43:Issue 5(2017:May) Page Start: 921 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗